FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Maryalice Stetler-Stevenson

Research Profile

Procedures

Disorders

Chemicals & Drugs

Anatomy

Co-author Network

Publications

TOP 3
Haipeng Shao; Maryalice Stetler-Stevenson; Prashant R Tembhare; Katherine R Calvo; Marlene Grönborg; Robert J Kreitman; Constance M Yuan
Distinguishing hairy cell leukemia variant from hairy cell leukemia: development and validation of diagnostic criteria.
Amy D Klion; Tammy Krogmann; Irina Maric; Rojelio Mejia; Stefania Pittaluga; Calman Prussin; Mark Raffeld; Carlo Santos; Amber N Shatzer; Maryalice Stetler-Stevenson; Siu-Ping Turk; Liqiang Xi; Yuzhi Yin; Edward W Cowen; Kennichi C Dowdell; Kieron Dunleavy; Gary A Fahle; Nicole Holland-Thomas; Jeffrey I Cohen
Chronic active Epstein-Barr virus infection: a novel cause of lymphocytic variant hypereosinophilic syndrome.
Waleed Haso; Daniel W Lee; CRYSTAL MACKALL; Richard A Morgan; Ira H Pastan; Nirali N Shah; Maryalice Stetler-Stevenson; ALAN WAYNE; Constance M Yuan; David M Barrett; Dimiter S Dimitrov; David J FitzGerald; Rimas J Orentas
Anti-CD22-chimeric antigen receptors targeting B-cell precursor acute lymphoblastic leukemia.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Maryalice Stetler-Stevenson (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2013: Haipeng Shao; Maryalice Stetler-Stevenson; Prashant R Tembhare; Katherine R Calvo; Marlene Grönborg; Robert J Kreitman; Constance M Yuan
Distinguishing hairy cell leukemia variant from hairy cell leukemia: development and validation of diagnostic criteria.
Leukemia research 2013;37(4):401-9.
2013: Amy D Klion; Tammy Krogmann; Irina Maric; Rojelio Mejia; Stefania Pittaluga; Calman Prussin; Mark Raffeld; Carlo Santos; Amber N Shatzer; Maryalice Stetler-Stevenson; Siu-Ping Turk; Liqiang Xi; Yuzhi Yin; Edward W Cowen; Kennichi C Dowdell; Kieron Dunleavy; Gary A Fahle; Nicole Holland-Thomas; Jeffrey I Cohen
Chronic active Epstein-Barr virus infection: a novel cause of lymphocytic variant hypereosinophilic syndrome.
Blood 2013;121(12):2364-6.
2013: Waleed Haso; Daniel W Lee; CRYSTAL MACKALL; Richard A Morgan; Ira H Pastan; Nirali N Shah; Maryalice Stetler-Stevenson; ALAN WAYNE; Constance M Yuan; David M Barrett; Dimiter S Dimitrov; David J FitzGerald; Rimas J Orentas
Anti-CD22-chimeric antigen receptors targeting B-cell precursor acute lymphoblastic leukemia.
Blood 2013;121(7):1165-74.
2012: Joo Y Song; Maryalice Stetler-Stevenson; David Venzon; Armando C Filie; Constance M Yuan
Flow cytometry increases the sensitivity of detection of leukemia and lymphoma cells in bronchoalveolar lavage specimens.
Cytometry. Part B, Clinical cytometry 2012;82(5):305-12.
2012: Nirali N Shah; Maryalice Stetler-Stevenson; Barbara Wise; Diane C Arthur; Ulrike Bacher; Kristin Baird; Michael Bishop; Katherine R Calvo; Terry Fry; Sergio Giralt; Nancy M Hardy; Roger Kurlander; ALAN WAYNE
Myelodysplastic syndrome after allogeneic hematopoietic stem cell transplantation: diagnostic and therapeutic challenges.
American journal of hematology 2012;87(9):916-22.
2012: Robert J Kreitman; Robert Lechleider; Steven Coutre; David J Fitzgerald; Tadeusz Robak; Maryalice Stetler-Stevenson; Martin S Tallman; Wyndham H Wilson; Ira Pastan
Phase I trial of anti-CD22 recombinant immunotoxin moxetumomab pasudotox (CAT-8015 or HA22) in patients with hairy cell leukemia.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2012;30(15):1822-8.
2012: Prashant Tembhare; Liqiang Xi; Constance M Yuan; Gerald Marti; Mark Raffeld; Maryalice Stetler-Stevenson
Case study interpretation--Portland: Case 1. Hairy cell leukemia with CLL-like monoclonal B lymphocytosis.
Cytometry. Part B, Clinical cytometry 2012;82(3):177-9.
2012: Liqiang Xi; Evgeny Arons; Katherine R Calvo; Winnifred Navarro; Mark Raffeld; Maryalice Stetler-Stevenson; Robert J Kreitman
Both variant and IGHV4-34-expressing hairy cell leukemia lack the BRAF V600E mutation.
Blood 2012;119(14):3330-2.
2012: Nancy M Hardy; Carl H June; Hanh M Khuu; Roger J Kurlander; Bruce L Levine; Sarfraz Memon; Esther Mena; Jeanne Odom; Stefania Pittaluga; Ran Reshef; Jeremy J Rose; Seth M Steinberg; Maryalice Stetler-Stevenson; Robert H Vonderheide; Bazetta Blacklock-Schuver; Andrew J Dwyer; Vicki Fellowes; Daniel H Fowler; Ronald E Gress; Frances T Hakim; Daniele N Avila; Michael Bishop
Costimulated tumor-infiltrating lymphocytes are a feasible and safe alternative donor cell therapy for relapse after allogeneic stem cell transplantation.
Blood 2012;119(12):2956-9.
2012: James N Kochenderfer; Carolyn Laurencot; Irina Maric; Richard A Morgan; Debbie-Ann N Nathan; Giao Q Phan; Robert Carpenter; Laura Devillier; Mark E Dudley; Steven A Feldman; Marybeth S Hughes; Udai S Kammula; Richard M Sherry; David E Spaner; Maryalice Stetler-Stevenson; Wyndham H Wilson; James C Yang; STEVEN ROSENBERG
B-cell depletion and remissions of malignancy along with cytokine-associated toxicity in a clinical trial of anti-CD19 chimeric-antigen-receptor-transduced T cells.
Blood 2012;119(12):2709-20.
2012: Prashant Tembhare; Constance M Yuan; Armando C Filie; John E Janik; John C Morris; Maryalice Stetler-Stevenson
Flow cytometric immunophenotypic assessment of T-cell clonality by vβ repertoire analysis in fine-needle aspirates and cerebrospinal fluid.
American journal of clinical pathology 2012;137(2):220-6.
2011: Gerald E Marti; Seth M Steinberg; Maryalice Stetler-Stevenson; Tanyifor Tohnya; Therese White; Kieron Dunleavy; William D Figg; Nicole Drbohlav Grant; Elaine S Jaffe; John E Janik; Wyndham H Wilson
Phase I trial of 7-hydroxystaurosporine and fludararbine phosphate: in vivo evidence of 7-hydroxystaurosporine induced apoptosis in chronic lymphocytic leukemia.
Leukemia & lymphoma 2011;52(12):2284-92.
2011: Girish Venkataraman; Constance M Yuan; Christine Aguhar; Robert J Kreitman; Maryalice Stetler-Stevenson
Characteristic CD103 and CD123 expression pattern defines hairy cell leukemia: usefulness of CD123 and CD103 in the diagnosis of mature B-cell lymphoproliferative disorders.
American journal of clinical pathology 2011;136(4):625-30.
2011: Katherine R Calvo; Amalia Dutra; Dennis D Hickstein; Diane C Arthur; Amy P Hsu; Irina Maric; Kyungjae Myung; Pierre Noel; Evgenia Pak; Stefania Pittaluga; Mark Raffeld; Maryalice Stetler-Stevenson; Donald Vinh; Weixin Wang; Steven M Holland
Myelodysplasia in autosomal dominant and sporadic monocytopenia immunodeficiency syndrome: diagnostic features and clinical implications.
Haematologica 2011;96(8):1221-5.
2011: Robert J Kreitman; Evgeny Arons; Maryalice Stetler-Stevenson; David J P Fitzgerald; Wyndham H Wilson; Ira Pastan
Recombinant immunotoxins and other therapies for relapsed/refractory hairy cell leukemia.
Leukemia & lymphoma 2011;52 Suppl 2():82-6.
2011: Prashant Tembhare; Constance M Yuan; Liqiang Xi; John C Morris; David Liewehr; David Venzon; John E Janik; Mark Raffeld; Maryalice Stetler-Stevenson
Flow cytometric immunophenotypic assessment of T-cell clonality by Vβ repertoire analysis: detection of T-cell clonality at diagnosis and monitoring of minimal residual disease following therapy.
American journal of clinical pathology 2011;135(6):890-900.
2011: Maryalice Stetler-Stevenson; Prashant R Tembhare
Diagnosis of hairy cell leukemia by flow cytometry.
Leukemia & lymphoma 2011;52 Suppl 2():11-3.
2011: Robert J Kreitman; Evgeny Arons; Maryalice Stetler-Stevenson; Kenneth B Miller
Response of hairy cell leukemia to bendamustine.
Leukemia & lymphoma 2011;52(6):1153-6.
2011: Evgeny Arons; Laura Roth; Jeffrey Sapolsky; Tara Suntum; Maryalice Stetler-Stevenson; Robert J Kreitman
Evidence of canonical somatic hypermutation in hairy cell leukemia.
Blood 2011;117(18):4844-51.
2011: Gregory A Jasper; Indu Arun; David Venzon; Robert J Kreitman; ALAN WAYNE; Constance M Yuan; Gerald E Marti; Maryalice Stetler-Stevenson
Variables affecting the quantitation of CD22 in neoplastic B cells.
Cytometry. Part B, Clinical cytometry 2011;80(2):83-90.
2011: Patricia Pérez-Galán; Helena Mora-Jensen; Marc A Weniger; Arthur L Shaffer; Edgar G Rizzatti; Colby M Chapman; Clifton C Mo; Lawrence S Stennett; Christoph Rader; Poching Liu; Nalini Raghavachari; Maryalice Stetler-Stevenson; Constance Yuan; Stefania Pittaluga; Irina Maric; Kieron M Dunleavy; Wyndham H Wilson; Louis M Staudt; Adrian Wiestner
Bortezomib resistance in mantle cell lymphoma is associated with plasmacytic differentiation.
Blood 2011;117(2):542-52.
2011: Yair Herishanu; Patricia Pérez-Galán; Delong Liu; Angélique Biancotto; Stefania Pittaluga; Berengere Vire; Federica Gibellini; Ndegwa Njuguna; Elinor Lee; Lawrence Stennett; Nalini Raghavachari; Poching Liu; J Philip McCoy; Mark Raffeld; Maryalice Stetler-Stevenson; Constance Yuan; Richard Sherry; Diane C Arthur; Irina Maric; Therese White; Gerald E Marti; Peter J Munson; Wyndham H Wilson; Adrian Wiestner
The lymph node microenvironment promotes B-cell receptor signaling, NF-kappaB activation, and tumor proliferation in chronic lymphocytic leukemia.
Blood 2011;117(2):563-74.
2011: Constance M Yuan; Maryalice Stetler-Stevenson
Role of flow cytometry of peripheral blood and bone marrow aspirates in early myeloma.
Seminars in hematology 2011;48(1):32-8.
2011: Katherine R Calvo; Catharine S McCoy; Maryalice Stetler-Stevenson
Flow cytometry immunophenotyping of hematolymphoid neoplasia.
Methods in molecular biology (Clifton, N.J.) 2011;699():295-316.
2011: Lili Wang; Fatima Abbasi; Gregory A Jasper; Robert J Kreitman; David J Liewehr; Gerald E Marti; Maryalice Stetler-Stevenson
Variables in the quantification of CD4 in normals and hairy cell leukemia patients.
Cytometry. Part B, Clinical cytometry 2011;80(1):51-6.
2010: James N Kochenderfer; Wyndham H Wilson; John E Janik; Mark E Dudley; Maryalice Stetler-Stevenson; Steven A Feldman; Irina Maric; Mark Raffeld; Debbie-Ann N Nathan; Brock J Lanier; Richard A Morgan; STEVEN ROSENBERG
Eradication of B-lineage cells and regression of lymphoma in a patient treated with autologous T cells genetically engineered to recognize CD19.
Blood 2010;116(20):4099-102.
2010: Francis Mussai; Dario Campana; Deepa Bhojwani; Maryalice Stetler-Stevenson; Seth M Steinberg; ALAN WAYNE; Ira Pastan
Cytotoxicity of the anti-CD22 immunotoxin HA22 (CAT-8015) against paediatric acute lymphoblastic leukaemia.
British journal of haematology 2010;150(3):352-8.
2010: Steven Yeh; Eric D Weichel; Lisa J Faia; Thomas Albini; Keith K Wroblewski; Maryalice Stetler-Stevenson; Phillip Ruiz; H Nida Sen; Chi-Chao Chan; Robert B Nussenblatt
25-Gauge transconjunctival sutureless vitrectomy for the diagnosis of intraocular lymphoma.
The British journal of ophthalmology 2010;94(5):633-8.
2010: Indu Arun; Jacqueline A Wulu; John E Janik; Gregory A Jasper; Constance M Yuan; David Venzon; Maryalice Stetler-Stevenson
Visual inspection versus quantitative flow cytometry to detect aberrant CD2 expression in malignant T cells.
Cytometry. Part B, Clinical cytometry 2010;78(3):169-75.
2010: Haipeng Shao; Constance M Yuan; Liqiang Xi; Mark Raffeld; John C Morris; John E Janik; Maryalice Stetler-Stevenson
Minimal residual disease detection by flow cytometry in adult T-cell leukemia/lymphoma.
American journal of clinical pathology 2010;133(4):592-601.
2010: ALAN WAYNE; Robert J Kreitman; Harry W Findley; Glen Lew; Cynthia Delbrook; Seth M Steinberg; Maryalice Stetler-Stevenson; David J Fitzgerald; Ira Pastan
Anti-CD22 immunotoxin RFB4(dsFv)-PE38 (BL22) for CD22-positive hematologic malignancies of childhood: preclinical studies and phase I clinical trial.
Clinical cancer research : an official journal of the American Association for Cancer Research 2010;16(6):1894-903.
2010: Claude Sportès; Rebecca R. Babb; Michael C Krumlauf; Frances T Hakim; Seth M Steinberg; Catherine K Chow; Margaret R Brown; Thomas A Fleisher; Pierre Noel; Irina Maric; Maryalice Stetler-Stevenson; Julie Engel; Renaud Buffet; Michel MORRE; Robert J Amato; Andrew L Pecora; CRYSTAL MACKALL; Ronald E Gress
Phase I study of recombinant human interleukin-7 administration in subjects with refractory malignancy.
Clinical cancer research : an official journal of the American Association for Cancer Research 2010;16(2):727-35.
2009: Evgeny Arons; Tara Suntum; Maryalice Stetler-Stevenson; Robert J Kreitman
VH4-34+ hairy cell leukemia, a new variant with poor prognosis despite standard therapy.
Blood 2009;114(21):4687-95.
2009: Richard L Piekarz; Robin Frye; Maria Turner; John J Wright; Steven Allen; Mark H Kirschbaum; Jasmine Zain; H Miles Prince; John P Leonard; Larisa J Geskin; Craig Reeder; David Joske; William D Figg; Erin R Gardner; Seth M Steinberg; Elaine S Jaffe; Maryalice Stetler-Stevenson; Stephen Lade; A Tito Fojo; Susan E Bates
Phase II multi-institutional trial of the histone deacetylase inhibitor romidepsin as monotherapy for patients with cutaneous T-cell lymphoma.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2009;27(32):5410-7.
2009: Maryalice Stetler-Stevenson
Flow cytometric immunophenotyping: emerging as an important diagnostic tool in the evaluation of cytopenic patients.
Leukemia research 2009;33(8):1020-1.
2009: Robert J Kreitman; Maryalice Stetler-Stevenson; Inger Margulies; Pierre Noel; David J P Fitzgerald; Wyndham H Wilson; Ira Pastan
Phase II trial of recombinant immunotoxin RFB4(dsFv)-PE38 (BL22) in patients with hairy cell leukemia.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2009;27(18):2983-90.
2009: Deirdre O'Mahony; John C Morris; Maryalice Stetler-Stevenson; Helen Matthews; Margaret R Brown; Thomas Fleisher; Stefania Pittaluga; Mark Raffeld; Paul S Albert; Dirk Reitsma; Karen L Kaucic; Luz D Hammershaimb; Thomas Waldmann; John E Janik
EBV-related lymphoproliferative disease complicating therapy with the anti-CD2 monoclonal antibody, siplizumab, in patients with T-cell malignancies.
Clinical cancer research : an official journal of the American Association for Cancer Research 2009;15(7):2514-22.
2009: Liuyan Jiang; Constance M Yuan; Julia Hubacheck; John E Janik; Wyndham Wilson; John C Morris; Gregory A Jasper; Maryalice Stetler-Stevenson
Variable CD52 expression in mature T cell and NK cell malignancies: implications for alemtuzumab therapy.
British journal of haematology 2009;145(2):173-9.
2009: Kathryn Rizzo; Maryalice Stetler-Stevenson; Wyndham Wilson; Constance M Yuan
Novel CD19 expression in a peripheral T cell lymphoma: A flow cytometry case report with morphologic correlation.
Cytometry. Part B, Clinical cytometry 2009;76(2):142-9.
2009: Liuyan Jiang; Andrea D Abati; Wyndham Wilson; Maryalice Stetler-Stevenson; Constance Yuan
Persistent non-neoplastic gammadelta-T cells in cerebrospinal fluid of a patient with hepatosplenic (gammadelta) T cell lymphoma: a case report with 6 years of flow cytometry follow-up.
International journal of clinical and experimental pathology 2009;3(1):110-6.
2008: Young-Sik Kim; Dong-Wan Seo; Su-Kang Kong; Ju-Han Lee; Eung Seok Lee; Maryalice Stetler-Stevenson; William Stetler-Stevenson
TIMP1 induces CD44 expression and the activation and nuclear translocation of SHP1 during the late centrocyte/post-germinal center B cell differentiation.
Cancer letters 2008;269(1):37-45.
2008: Kakushi Matsushita; Inger Margulies; Masanori Onda; Satoshi Nagata; Maryalice Stetler-Stevenson; Robert J Kreitman
Soluble CD22 as a tumor marker for hairy cell leukemia.
Blood 2008;112(6):2272-7.
2008: Evgeny Arons; Tara Suntum; Inger Margulies; Constance Yuan; Maryalice Stetler-Stevenson; Robert J Kreitman
PRAME expression in hairy cell leukemia.
Leukemia research 2008;32(9):1400-6.
2008: Jaco Kraan; Jan W Gratama; Corinne Haioun; Alberto Orfao; Anne Plonquet; Anna Porwit; Sandra Quijano; Maryalice Stetler-Stevenson; Dolores Subira; Wyndham Wilson
Flow cytometric immunophenotyping of cerebrospinal fluid.
Current protocols in cytometry / editorial board, J. Paul Robinson, managing editor ... [et al.] 2008;Chapter 6():Unit 6.25.
2008: Ejaz Ahmad; Seth M Steinberg; Lynn Goldin; Christopher J Hess; Neil Caporaso; Robert J Kreitman; Adrian Wiestner; Wyndham Wilson; Therese White; Gerald E Marti; Maryalice Stetler-Stevenson
Immunophenotypic features distinguishing familial chronic lymphocytic leukemia from sporadic chronic lymphocytic leukemia.
Cytometry. Part B, Clinical cytometry 2008;74(4):221-6.
2008: Xing Du; Satoshi Nagata; Tomoko Ise; Maryalice Stetler-Stevenson; Ira Pastan
FCRL1 on chronic lymphocytic leukemia, hairy cell leukemia, and B-cell non-Hodgkin lymphoma as a target of immunotoxins.
Blood 2008;111(1):338-43.
2007: Nancy M Hardy; Christine Grady; Rebecca Pentz; Maryalice Stetler-Stevenson; Mark Raffeld; Laura Fontaine; Rebecca R. Babb; Michael Bishop; Neil Caporaso; Gerald E Marti
Bioethical considerations of monoclonal B-cell lymphocytosis: donor transfer after haematopoietic stem cell transplantation.
British journal of haematology 2007;139(5):824-31.
2007: Fatima Abbasi; Nancy S Longo; Peter E Lipsky; Elizabeth Raveche; Therese A Schleinitz; Maryalice Stetler-Stevenson; Neil Caporaso; Gerald E Marti
B-cell repertoire and clonal analysis in unaffected first degree relatives in familial chronic lymphocytic leukaemia kindred.
British journal of haematology 2007;139(5):820-3.
2007: Evgeny Arons; Tara Suntum; Joel Sunshine; Maryalice Stetler-Stevenson; Robert J Kreitman
Immunoglobulin light chain repertoire in hairy cell leukemia.
Leukemia research 2007;31(9):1231-6.
2007: B H Davis; J T Holden; marie bene; Michael J Borowitz; Raul C Braylan; D Cornfield; W Gorczyca; R Lee; R Maiese; A Orfao; D Wells; B L Wood; Maryalice Stetler-Stevenson
2006 Bethesda International Consensus recommendations on the flow cytometric immunophenotypic analysis of hematolymphoid neoplasia: medical indications.
Cytometry. Part B, Clinical cytometry 2007;72 Suppl 1():S5-13.
2007: Maryalice Stetler-Stevenson; Bruce Davis; Brent Wood; Raul C Braylan
2006 Bethesda International Consensus Conference on Flow Cytometric Immunophenotyping of Hematolymphoid Neoplasia.
Cytometry. Part B, Clinical cytometry 2007;72 Suppl 1():S3.
2007: T Ise; Satoshi Nagata; Robert J Kreitman; Wyndham H Wilson; ALAN WAYNE; Maryalice Stetler-Stevenson; Michael Bishop; David A Scheinberg; Laura Rassenti; Thomas Kipps; R A Kyle; D F Jelinek; Ira Pastan
Elevation of soluble CD307 (IRTA2/FcRH5) protein in the blood and expression on malignant cells of patients with multiple myeloma, chronic lymphocytic leukemia, and mantle cell lymphoma.
Leukemia 2007;21(1):169-74.
2006: Evgeny Arons; Lynn Sorbara; Mark Raffeld; Maryalice Stetler-Stevenson; Seth M Steinberg; David J Liewehr; Ira Pastan; Robert J Kreitman
Characterization of T-cell repertoire in hairy cell leukemia patients before and after recombinant immunotoxin BL22 therapy.
Cancer immunology, immunotherapy : CII 2006;55(9):1100-10.
2006: Malcolm Schinstine; Armando C Filie; Wyndham Wilson; Maryalice Stetler-Stevenson; Andrea Abati
Detection of malignant hematopoietic cells in cerebral spinal fluid previously diagnosed as atypical or suspicious.
Cancer 2006;108(3):157-62.
2006: STEVEN ROSENBERG; Claude Sportès; Mojgan Ahmadzadeh; Terry J Fry; Lien T Ngo; Susan L Schwarz; Maryalice Stetler-Stevenson; Kathleen E Morton; Sharon A Mavroukakis; Michel MORRE; Renaud Buffet; CRYSTAL MACKALL; Ronald E Gress
IL-7 administration to humans leads to expansion of CD8+ and CD4+ cells but a relative decrease of CD4+ T-regulatory cells.
Journal of immunotherapy (Hagerstown, Md. : 1997) 2006;29(3):313-9.
2006: Evgeny Arons; Inger Margulies; Lynn Sorbara; Mark Raffeld; Maryalice Stetler-Stevenson; Ira Pastan; Robert J Kreitman
Minimal residual disease in hairy cell leukemia patients assessed by clone-specific polymerase chain reaction.
Clinical cancer research : an official journal of the American Association for Cancer Research 2006;12(9):2804-11.
2005: T Aurran-Schleinitz; W Telford; Stephen P Perfetto; Neil Caporaso; W Wilson; Maryalice Stetler-Stevenson; Vincent E Zenger; Fatima Abbasi; Gerald E Marti
Identification of a new monoclonal B-cell subset in unaffected first-degree relatives in familial chronic lymphocytic leukemia.
Leukemia 2005;19(12):2339-41.
2005: Robert J Kreitman; David R Squires; Maryalice Stetler-Stevenson; Pierre Noel; David J P FitzGerald; Wyndham H Wilson; Ira Pastan
Phase I trial of recombinant immunotoxin RFB4(dsFv)-PE38 (BL22) in patients with B-cell malignancies.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2005;23(27):6719-29.
2005: Sattva S Neelapu; Larry W Kwak; CAROL KOBRIN; Craig W Reynolds; John Janik; Kieron Dunleavy; Therese White; Linda Harvey; Robin Pennington; Maryalice Stetler-Stevenson; Elaine S Jaffe; Seth M Steinberg; Ronald E Gress; Frances T Hakim; Wyndham H Wilson
Vaccine-induced tumor-specific immunity despite severe B-cell depletion in mantle cell lymphoma.
Nature medicine 2005;11(9):986-91.
2005: Ejaz Ahmad; Douglas W Kingma; Elaine S Jaffe; Jeffrey A Schrager; John Janik; Wyndham Wilson; Maryalice Stetler-Stevenson
Flow cytometric immunophenotypic profiles of mature gamma delta T-cell malignancies involving peripheral blood and bone marrow.
Cytometry. Part B, Clinical cytometry 2005;67(1):6-12.
2005: Patrick F Fogarty; Maryalice Stetler-Stevenson; Aloysius Pereira; Cynthia E Dunbar
Large granular lymphocytic proliferation-associated cyclic thrombocytopenia.
American journal of hematology 2005;79(4):334-6.
2005: Lawrence S Lamb; Ron Neuberg; Jeff Welsh; Robert G Best; Maryalice Stetler-Stevenson; April Sorrell
T-cell lymphoblastic leukemia/lymphoma syndrome with eosinophilia and acute myeloid leukemia.
Cytometry. Part B, Clinical cytometry 2005;65(1):37-41.
2005: Liliana Guedez; Antonio Martinez; Shumei Zhao; Angelica Vivero; Stefania Pittaluga; Maryalice Stetler-Stevenson; Mark Raffeld; William Stetler-Stevenson
Tissue inhibitor of metalloproteinase 1 (TIMP-1) promotes plasmablastic differentiation of a Burkitt lymphoma cell line: implications in the pathogenesis of plasmacytic/plasmablastic tumors.
Blood 2005;105(4):1660-8.
2005: Upendra Hegde; Armando C Filie; Richard F Little; John Janik; Nicole Grant; Seth M Steinberg; Kieron Dunleavy; Elaine S Jaffe; Andrea Abati; Maryalice Stetler-Stevenson; Wyndham H Wilson
High incidence of occult leptomeningeal disease detected by flow cytometry in newly diagnosed aggressive B-cell lymphomas at risk for central nervous system involvement: the role of flow cytometry versus cytology.
Blood 2005;105(2):496-502.
2004: Peter Haviernik; Carisa Lahoda; Heath L Bradley; Teresa S Hawley; Ali Ramezani; Robert G Hawley; Maryalice Stetler-Stevenson; William Stetler-Stevenson; Kevin D Bunting
Tissue inhibitor of matrix metalloproteinase-1 overexpression in M1 myeloblasts impairs IL-6-induced differentiation.
Oncogene 2004;23(57):9212-9.
2004: Matthew Lunning; Vincent E Zenger; Ricardo Dreyfuss; Maryalice Stetler-Stevenson; Margaret E Rick; Therese A White; Wyndham H Wilson; Gerald E Marti
Albumin enhanced morphometric image analysis in CLL.
Cytometry. Part B, Clinical cytometry 2004;57(1):7-14.
2003: Maryalice Stetler-Stevenson
Flow cytometry in lymphoma diagnosis and prognosis: useful?
Best practice & research. Clinical haematology 2003;16(4):583-97.
2003: Gerald E Marti; Robert F Vogt; Maryalice Stetler-Stevenson
Clinical quantitative flow cytometry: "Identifying the optimal methods for clinical quantitative flow cytometry".
Cytometry. Part B, Clinical cytometry 2003;55(1):59.
2003: Adrian Wiestner; Andreas Rosenwald; Todd S Barry; George Wright; R Eric Davis; Sarah Henrickson; Hong Zhao; Rachel E Ibbotson; Jenny A Orchard; Zadie Davis; Maryalice Stetler-Stevenson; Mark Raffeld; Diane C Arthur; Gerald E Marti; Wyndham H Wilson; Terry J Hamblin; David Oscier; Louis M Staudt
ZAP-70 expression identifies a chronic lymphocytic leukemia subtype with unmutated immunoglobulin genes, inferior clinical outcome, and distinct gene expression profile.
Blood 2003;101(12):4944-51.
2003: Gerald E Marti; Patricia Carter; Fatima Abbasi; Glennelle C Washington; Nisha Jain; Vincent E Zenger; Naoko Ishibe; Lynn R Goldin; Laura Fontaine; Nancy Weissman; Maria Sgambati; Guy Fauget; Pablo Bertin; Robert F Vogt; Barbara Slade; Philip D Noguchi; Maryalice Stetler-Stevenson; Neil Caporaso
B-cell monoclonal lymphocytosis and B-cell abnormalities in the setting of familial B-cell chronic lymphocytic leukemia.
Cytometry. Part B, Clinical cytometry 2003;52(1):1-12.
2003: Justin E Sausville; Rita G Salloum; Lynn Sorbara; Douglas W Kingma; Mark Raffeld; Robert J Kreitman; Paula D Imus; David Venzon; Maryalice Stetler-Stevenson
Minimal residual disease detection in hairy cell leukemia. Comparison of flow cytometric immunophenotyping with clonal analysis using consensus primer polymerase chain reaction for the heavy chain gene.
American journal of clinical pathology 2003;119(2):213-7.
2002: Douglas W Kingma; Paula Imus; Xiu Y Xie; Gregory Jasper; Lynn Sorbara; Carleton Stewart; Maryalice Stetler-Stevenson
CD2 is expressed by a subpopulation of normal B cells and is frequently present in mature B-cell neoplasms.
Cytometry 2002;50(5):243-8.
2002: Matthew Lunning; Maryalice Stetler-Stevenson; Peter T Silberstein; Vincent E Zenger; Gerald E Marti
Spontaneous (pathological) splenic rupture in a blastic variant of mantle cell lymphoma: a case report and literature review.
Clinical lymphoma 2002;3(2):117-20.
2002: Laila Dahmoush; Yasmine Hijazi; Earl Barnes; Maryalice Stetler-Stevenson; Andrea Abati
Adult T-cell leukemia/lymphoma: a cytopathologic, immunocytochemical, and flow cytometric study.
Cancer 2002;96(2):110-6.
2001: Maryalice Stetler-Stevenson; Diane C Arthur; N Jabbour; Xiu Y Xie; Jeffrey J Molldrem; A John Barrett; David Venzon; M E Rick
Diagnostic utility of flow cytometric immunophenotyping in myelodysplastic syndrome.
Blood 2001;98(4):979-87.
2001: Robert J Kreitman; Wyndham H Wilson; K Bergeron; M Raggio; Maryalice Stetler-Stevenson; David J FitzGerald; Ira Pastan
Efficacy of the anti-CD22 recombinant immunotoxin BL22 in chemotherapy-resistant hairy-cell leukemia.
The New England journal of medicine 2001;345(4):241-7.
2001: Maryalice Stetler-Stevenson; Raul C Braylan
Flow cytometric analysis of lymphomas and lymphoproliferative disorders.
Seminars in hematology 2001;38(2):111-23.
2001: G E Marti; Maryalice Stetler-Stevenson; Jack J H Bleesing; Thomas A Fleisher
Introduction to flow cytometry.
Seminars in hematology 2001;38(2):93-9.
2001: Liliana Guedez; AJ McMarlin; Douglas W Kingma; T A Bennett; Maryalice Stetler-Stevenson; William Stetler-Stevenson
Tissue inhibitor of metalloproteinase-1 alters the tumorigenicity of Burkitt's lymphoma via divergent effects on tumor growth and angiogenesis.
The American journal of pathology 2001;158(4):1207-15.
2001: Liliana Guedez; A Mansoor; B Birkedal-Hansen; Megan S Lim; PI Fukushima; David Venzon; William Stetler-Stevenson; Maryalice Stetler-Stevenson
Tissue inhibitor of metalloproteinases 1 regulation of interleukin-10 in B-cell differentiation and lymphomagenesis.
Blood 2001;97(6):1796-802.
2001: Yogen Saunthararajah; J L Molldrem; Mary Rivera; A Williams; Maryalice Stetler-Stevenson; Lynn Sorbara; Neal S Young; John A Barrett
Coincident myelodysplastic syndrome and T-cell large granular lymphocytic disease: clinical and pathophysiological features.
British journal of haematology 2001;112(1):195-200.
2000: Qun Zhou; PI Fukushima; William DeGraff; James B Mitchell; Maryalice Stetler-Stevenson; A Ashkenazi; Patricia S Steeg
Radiation and the Apo2L/TRAIL apoptotic pathway preferentially inhibit the colonization of premalignant human breast cells overexpressing cyclin D1.
Cancer research 2000;60(10):2611-5.
2000: Xiu Y Xie; Armando C Filie; G A Jasper; PI Fukushima; Maryalice Stetler-Stevenson
Diagnosis of unexpected acute myeloid leukemia and chronic lymphocytic leukemia: a case report demonstrating the perils of restricted panels in flow cytometric immunophenotyping.
Cytometry 2000;42(2):114-7.
2000: Robert J Kreitman; Inger Margulies; Maryalice Stetler-Stevenson; Qing-Cheng Wang; David J FitzGerald; Ira Pastan
Cytotoxic activity of disulfide-stabilized recombinant immunotoxin RFB4(dsFv)-PE38 (BL22) toward fresh malignant cells from patients with B-cell leukemias.
Clinical cancer research : an official journal of the American Association for Cancer Research 2000;6(4):1476-87.
2000: Richard A Messmann; Ellen S Vitetta; Donna Headlee; Adrian M Senderowicz; William D Figg; John Schindler; D F Michiel; Stephen Creekmore; Seth M Steinberg; David R Kohler; Elaine S Jaffe; Maryalice Stetler-Stevenson; H Chen; Victor Ghetie; Edward A Sausville
A phase I study of combination therapy with immunotoxins IgG-HD37-deglycosylated ricin A chain (dgA) and IgG-RFB4-dgA (Combotox) in patients with refractory CD19(+), CD22(+) B cell lymphoma.
Clinical cancer research : an official journal of the American Association for Cancer Research 2000;6(4):1302-13.
2000: Robert J Kreitman; Wyndham H Wilson; Jeffrey D White; Maryalice Stetler-Stevenson; Elaine S Jaffe; S Giardina; Thomas Waldmann; Ira Pastan
Phase I trial of recombinant immunotoxin anti-Tac(Fv)-PE38 (LMB-2) in patients with hematologic malignancies.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2000;18(8):1622-36.
2000: Xiu Y Xie; Lynn Sorbara; Robert J Kreitman; PI Fukushima; Douglas W Kingma; Maryalice Stetler-Stevenson
Development of lymphoproliferative disorder of granular lymphocytes in association with hairy cell leukemia.
Leukemia & lymphoma 2000;37(1-2):97-104.
2000: D H Robbins; Inger Margulies; Maryalice Stetler-Stevenson; Robert J Kreitman
Hairy cell leukemia, a B-cell neoplasm that is particularly sensitive to the cytotoxic effect of anti-Tac(Fv)-PE38 (LMB-2).
Clinical cancer research : an official journal of the American Association for Cancer Research 2000;6(2):693-700.
2000: Qun Zhou; Julia D Wulfkuhle; Taoufik Ouatas; PI Fukushima; Maryalice Stetler-Stevenson; Fred R Miller; Patricia S Steeg
Cyclin D1 overexpression in a model of human breast premalignancy: preferential stimulation of anchorage-independent but not anchorage-dependent growth is associated with increased cdk2 activity.
Breast cancer research and treatment 2000;59(1):27-39.
1999: J McClanahan; PI Fukushima; Maryalice Stetler-Stevenson
Increased peripheral blood gamma delta T-cells in patients with lymphoid neoplasia: A diagnostic dilemma in flow cytometry.
Cytometry 1999;38(6):280-5.
1999: Robert J Kreitman; Wyndham H Wilson; D Robbins; Inger Margulies; Maryalice Stetler-Stevenson; Thomas Waldmann; Ira Pastan
Responses in refractory hairy cell leukemia to a recombinant immunotoxin.
Blood 1999;94(10):3340-8.
1999: Megan S Lim; Liliana Guedez; William Stetler-Stevenson; Maryalice Stetler-Stevenson
Tissue inhibitor of metalloproteinase-2 induces apoptosis in human T lymphocytes.
Annals of the New York Academy of Sciences 1999;878():522-3.
1998: Liliana Guedez; William Stetler-Stevenson; Linda Wolff; J Wang; PI Fukushima; A Mansoor; Maryalice Stetler-Stevenson
In vitro suppression of programmed cell death of B cells by tissue inhibitor of metalloproteinases-1.
The Journal of clinical investigation 1998;102(11):2002-10.
1998: Megan S Lim; Stephen E Straus; Janet K Dale; Thomas A Fleisher; Maryalice Stetler-Stevenson; W Strober; michael sneller; Jennifer M Puck; Michael J Lenardo; Kojo Seys John Elenitoba-Johnson; Albert Y Lin; Mark Raffeld; Elaine S Jaffe
Pathological findings in human autoimmune lymphoproliferative syndrome.
The American journal of pathology 1998;153(5):1541-50.
1998: Liliana Guedez; L Courtemanch; Maryalice Stetler-Stevenson
Tissue inhibitor of metalloproteinase (TIMP)-1 induces differentiation and an antiapoptotic phenotype in germinal center B cells.
Blood 1998;92(4):1342-9.
1997: Michael J Borowitz; Robert A. Bray; R Gascoyne; S Melnick; J W Parker; Louis J Picker; Maryalice Stetler-Stevenson
U.S.-Canadian Consensus recommendations on the immunophenotypic analysis of hematologic neoplasia by flow cytometry: data analysis and interpretation.
Cytometry 1997;30(5):236-44.
1997: A Wellmann; Victoria Doseeva; Wayne G Butscher; Mark Raffeld; PI Fukushima; Maryalice Stetler-Stevenson; Kevin Gardner
The activated anaplastic lymphoma kinase increases cellular proliferation and oncogene up-regulation in rat 1a fibroblasts.
FASEB journal : official publication of the Federation of American Societies for Experimental Biology 1997;11(12):965-72.
1997: Qun Zhou; Maryalice Stetler-Stevenson; Patricia S Steeg
Inhibition of cyclin D expression in human breast carcinoma cells by retinoids in vitro.
Oncogene 1997;15(1):107-15.
1997: Lawrence S Lamb; N F Robbins; Sunil Abhyankar; M Joyce; Maryalice Stetler-Stevenson; PJ Henslee-Downey; AP Gee
Flow cytometric cell sorting combined with molecular chimerism analysis to detect minimal recurrent leukemia: good news and bad news.
Bone marrow transplantation 1997;19(11):1157-61.
1997: Adrian M Senderowicz; Ellen S Vitetta; Donna Headlee; Victor Ghetie; Jonathan Uhr; William D Figg; Richard M Lush; Maryalice Stetler-Stevenson; G Kershaw; Douglas W Kingma; Elaine S Jaffe; Edward A Sausville
Complete sustained response of a refractory, post-transplantation, large B-cell lymphoma to an anti-CD22 immunotoxin.
Annals of internal medicine 1997;126(11):882-5.
1997: Maryalice Stetler-Stevenson; A Mansoor; Megan S Lim; PI Fukushima; J Kehrl; G Marti; K Ptaszynski; J Wang; William Stetler-Stevenson
Expression of matrix metalloproteinases and tissue inhibitors of metalloproteinases in reactive and neoplastic lymphoid cells.
Blood 1997;89(5):1708-15.
1996: PI Fukushima; P K Nguyen; P O'Grady; Maryalice Stetler-Stevenson
Flow cytometric analysis of kappa and lambda light chain expression in evaluation of specimens for B-cell neoplasia.
Cytometry 1996;26(4):243-52.
1996: J X Gray; M Haino; M J Roth; J E Maguire; P N Jensen; A Yarme; Maryalice Stetler-Stevenson; Ulrich Siebenlist; K Kelly
CD97 is a processed, seven-transmembrane, heterodimeric receptor associated with inflammation.
Journal of immunology (Baltimore, Md. : 1950) 1996;157(12):5438-47.
1996: T A Jacot; Gary E Striker; Maryalice Stetler-Stevenson; Liliane J Striker
Mesangial cells from transgenic mice with progressive glomerulosclerosis exhibit stable, phenotypic changes including undetectable MMP-9 and increased type IV collagen.
Laboratory investigation; a journal of technical methods and pathology 1996;75(6):791-9.
1996: C B Cooke; Laszlo Krenacs; Maryalice Stetler-Stevenson; T C Greiner; Mark Raffeld; Douglas W Kingma; Lynne V Abruzzo; Christopher Frantz; M Kaviani; Elaine S Jaffe
Hepatosplenic T-cell lymphoma: a distinct clinicopathologic entity of cytotoxic gamma delta T-cell origin.
Blood 1996;88(11):4265-74.
1996: lee stone; Edward A Sausville; Joseph W Fay; Donna Headlee; Robert H Collins; William D Figg; Maryalice Stetler-Stevenson; V Jain; E S Jaffe; D Solomon; Richard M Lush; Adrian M Senderowicz; Victor Ghetie; J Schindler; J W Uhr; Ellen S Vitetta
A phase I study of bolus versus continuous infusion of the anti-CD19 immunotoxin, IgG-HD37-dgA, in patients with B-cell lymphoma.
Blood 1996;88(4):1188-97.
1996: Z Bartośova; M Pirśel; William C Reinhold; Maryalice Stetler-Stevenson; Maria Zajac-Kaye; A May; ID Horak; Vilhelm A Bohr
Gene-specific repair in human CD4+ lymphocytes reflects transcription and proliferation.
Mutation research 1996;363(3):191-9.
1996: T Otsuki; Suresh Puri; Barbara Ensoli; Douglas W Kingma; T Yano; Maryalice Stetler-Stevenson; Elaine S Jaffe; Mark Raffeld
Detection of HHV-8/KSHV DNA sequences in AIDS-associated extranodal lymphoid malignancies.
Leukemia 1996;10(8):1358-62.
1996: Z H Liu; Gary E Striker; Maryalice Stetler-Stevenson; PI Fukushima; A Patel; Liliane J Striker
TNF-alpha and IL-1 alpha induce mannose receptors and apoptosis in glomerular mesangial but not endothelial cells.
The American journal of physiology 1996;270(6 Pt 1):C1595-601.
1996: J Wang; L J Medeiros; Dan Longo; A Mansoor; Mark Raffeld; P L Duffey; Elaine S Jaffe; Maryalice Stetler-Stevenson
Use of the polymerase chain reaction technique to determine c-myc expression in follicular center cell lymphoma.
Diagnostic molecular pathology : the American journal of surgical pathology, part B 1996;5(1):20-5.
1995: M J Roth; L J Medeiros; Kojo Seys John Elenitoba-Johnson; M Kuchnio; Elaine S Jaffe; Maryalice Stetler-Stevenson
Extramedullary myeloid cell tumors. An immunohistochemical study of 29 cases using routinely fixed and processed paraffin-embedded tissue sections.
Archives of pathology & laboratory medicine 1995;119(9):790-8.
1995: Y K Kang; Zhirong Zhan; JT Regis; M Alvarez; Robert W Robey; Beverly Meadows; B Dickstein; J S Lee; T Otsuki; Maryalice Stetler-Stevenson
Expression of mdr-1 in refractory lymphoma: quantitation by polymerase chain reaction and validation of the assay.
Blood 1995;86(4):1515-24.
1995: Edward A Sausville; Donna Headlee; Maryalice Stetler-Stevenson; Elaine S Jaffe; D Solomon; William D Figg; J Herdt; William Kopp; H Rager; Seth M Steinberg
Continuous infusion of the anti-CD22 immunotoxin IgG-RFB4-SMPT-dgA in patients with B-cell lymphoma: a phase I study.
Blood 1995;85(12):3457-65.
1995: R Wersto; Maryalice Stetler-Stevenson
Debris compensation of DNA histograms and its effect on S-phase analysis.
Cytometry 1995;20(1):43-52.
1994: M Kuchnio; Edward A Sausville; Elaine S Jaffe; T Greiner; Francine M Foss; J McClanahan; PI Fukushima; Maryalice Stetler-Stevenson
Flow cytometric detection of neoplastic T cells in patients with mycosis fungoides based on levels of T-cell receptor expression.
American journal of clinical pathology 1994;102(6):856-60.
1994: H C Hollingsworth; Maryalice Stetler-Stevenson; D Gagneten; Douglas W Kingma; Mark Raffeld; Elaine S Jaffe
Immunodeficiency-associated malignant lymphoma. Three cases showing genotypic evidence of both T- and B-cell lineages.
The American journal of surgical pathology 1994;18(11):1092-101.
1994: R Cohen; Elaine S Jaffe; Maryalice Stetler-Stevenson; Edward A Sausville; E C DeNigris; T Woodworth; Francine M Foss
Bilateral adrenal hemorrhage and adrenal insufficiency in a patient with lymphomatous adrenal infiltration following administration of a fusion toxin (DAB486 interleukin-2).
Journal of immunotherapy with emphasis on tumor immunology : official journal of the Society for Biological Therapy 1994;16(3):229-33.
1994: Francine M Foss; T A Borkowski; M Gilliom; Maryalice Stetler-Stevenson; Elaine S Jaffe; William D Figg; AC Tompkins; A Bastian; P Nylen; T Woodworth
Chimeric fusion protein toxin DAB486IL-2 in advanced mycosis fungoides and the Sezary syndrome: correlation of activity and interleukin-2 receptor expression in a phase II study.
Blood 1994;84(6):1765-74.
1994: Francine M Foss; Y Koc; Maryalice Stetler-Stevenson; D T Nguyen; M C O'Brien; R Turner; Edward A Sausville
Costimulation of cutaneous T-cell lymphoma cells by interleukin-7 and interleukin-2: potential autocrine or paracrine effectors in the Sézary syndrome.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1994;12(2):326-35.
1993: P J Worland; G Kaur; Maryalice Stetler-Stevenson; S Sebers; Oliver Sartor; Edward A Sausville
Alteration of the phosphorylation state of p34cdc2 kinase by the flavone L86-8275 in breast carcinoma cells. Correlation with decreased H1 kinase activity.
Biochemical pharmacology 1993;46(10):1831-40.
1993: J Wang; Mark Raffeld; L J Medeiros; Dan Longo; Elaine S Jaffe; P Duffey; Maryalice Stetler-Stevenson
Follicular center cell lymphoma with the t(14;18) translocation in which the rearranged BCL-2 gene is silent.
Leukemia 1993;7(11):1834-9.
1993: D C Metz; M Kuchnio; Douglas L Fraker; D J Venzon; G Jaffe; Robert T Jensen; Maryalice Stetler-Stevenson
Flow cytometry and Zollinger-Ellison syndrome: relationship to clinical course.
Gastroenterology 1993;105(3):799-813.
1993: Douglas J Schwartzentruber; Maryalice Stetler-Stevenson; STEVEN ROSENBERG; Suzanne Topalian
Tumor-infiltrating lymphocytes derived from select B-cell lymphomas secrete granulocyte-macrophage colony-stimulating factor and tumor necrosis factor-alpha in response to autologous tumor stimulation.
Blood 1993;82(4):1204-11.
1993: S K Bhagat; L J Medeiros; L M Weiss; J Wang; Mark Raffeld; Maryalice Stetler-Stevenson
bcl-2 expression in Hodgkin's disease. Correlation with the t(14;18) translocation and Epstein-Barr virus.
American journal of clinical pathology 1993;99(5):604-8.
1993: C M Seynaeve; Maryalice Stetler-Stevenson; S Sebers; G Kaur; Edward A Sausville; P J Worland
Cell cycle arrest and growth inhibition by the protein kinase antagonist UCN-01 in human breast carcinoma cells.
Cancer research 1993;53(9):2081-6.
1993: L J Medeiros; S K Bhagat; P Naylor; D Fowler; Elaine S Jaffe; Maryalice Stetler-Stevenson
Malignant thymoma associated with T-cell lymphocytosis. A case report with immunophenotypic and gene rearrangement analysis.
Archives of pathology & laboratory medicine 1993;117(3):279-83.
1992: G Kaur; Maryalice Stetler-Stevenson; S Sebers; P Worland; H Sedlacek; C Myers; J Czech; R Naik; Edward A Sausville
Growth inhibition with reversible cell cycle arrest of carcinoma cells by flavone L86-8275.
Journal of the National Cancer Institute 1992;84(22):1736-40.
1992: Elaine S Jaffe; Mark Raffeld; L J Medeiros; Maryalice Stetler-Stevenson
An overview of the classification of non-Hodgkin's lymphomas: an integration of morphological and phenotypical concepts.
Cancer research 1992;52(19 Suppl):5447s-5452s.
1992: michael sneller; Stephen E Straus; E S Jaffe; J S Jaffe; T A Fleisher; Maryalice Stetler-Stevenson; W Strober
A novel lymphoproliferative/autoimmune syndrome resembling murine lpr/gld disease.
The Journal of clinical investigation 1992;90(2):334-41.
1992: Edward G Mimnaugh; E Monti; S Sebers; Maryalice Stetler-Stevenson; B K Sinha
Synergistic antiproliferative effects of the combination of interleukin-1 alpha and doxorubicin against human melanoma cells.
Oncology research 1992;4(10):401-12.
1991: P Lardelli; R F Swaby; L J Medeiros; Elaine S Jaffe; R Rizzi; Maryalice Stetler-Stevenson
Determination of lineage and clonality in diffuse lymphomas using the polymerase chain reaction technique.
Human pathology 1991;22(7):685-9.
1991: L J Medeiros; P Lardelli; Maryalice Stetler-Stevenson; Dan Longo; Elaine S Jaffe
Genotypic analysis of diffuse, mixed cell lymphomas. Comparison with morphologic and immunophenotypic findings.
American journal of clinical pathology 1991;95(4):547-55.
1990: Maryalice Stetler-Stevenson; S Crush-Stanton; J Cossman
Involvement of the bcl-2 gene in Hodgkin's disease.
Journal of the National Cancer Institute 1990;82(10):855-8.